Harvey Investment Company’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.69M | Sell |
28,754
-500
| -2% | -$58.5K | 0.4% | 40 |
|
|
2026
Q1 | $3.52M | Hold |
29,254
| – | – | 0.39% | 42 |
|
|
2025
Q4 | $3.08M | Hold |
29,254
| – | – | 0.33% | 45 |
|
|
2025
Q3 | $2.46M | Hold |
29,254
| – | – | 0.26% | 45 |
|
|
2025
Q2 | $2.32M | Sell |
29,254
-34
| -0.1% | -$2.7K | 0.25% | 49 |
|
|
2025
Q1 | $2.63M | Hold |
29,288
| – | – | 0.29% | 46 |
|
|
2024
Q4 | $2.91M | Hold |
29,288
| – | – | 0.34% | 45 |
|
|
2024
Q3 | $3.33M | Hold |
29,288
| – | – | 0.38% | 44 |
|
|
2024
Q2 | $3.63M | Hold |
29,288
| – | – | 0.43% | 42 |
|
|
2024
Q1 | $3.87M | Hold |
29,288
| – | – | 0.44% | 43 |
|
|
2023
Q4 | $3.19M | Hold |
29,288
| – | – | 0.39% | 46 |
|
|
2023
Q3 | $3.02M | Hold |
29,288
| – | – | 0.39% | 45 |
|
|
2023
Q2 | $3.38M | Buy |
29,288
+34
| +0.1% | +$3.86K | 0.44% | 45 |
|
|
2023
Q1 | $3.11M | Hold |
29,254
| – | – | 0.39% | 45 |
|
|
2022
Q4 | $3.25M | Hold |
29,254
| – | – | 0.42% | 45 |
|
|
2022
Q3 | $2.52M | Hold |
29,254
| – | – | 0.37% | 45 |
|
|
2022
Q2 | $2.67M | Hold |
29,254
| – | – | 0.38% | 46 |
|
|
2022
Q1 | $2.4M | Hold |
29,254
| – | – | 0.29% | 50 |
|
|
2021
Q4 | $2.24M | Hold |
29,254
| – | – | 0.26% | 50 |
|
|
2021
Q3 | $2.2M | Hold |
29,254
| – | – | 0.29% | 48 |
|
|
2021
Q2 | $2.27M | Sell |
29,254
-1,404
| -5% | -$104K | 0.3% | 47 |
|
|
2021
Q1 | $2.25M | Sell |
30,658
-185
| -0.6% | -$13.6K | 0.32% | 47 |
|
|
2020
Q4 | $2.41M | Hold |
30,843
| – | – | 0.34% | 47 |
|
|
2020
Q3 | $2.44M | Hold |
30,843
| – | – | 0.38% | 45 |
|
|
2020
Q2 | $2.28M | Hold |
30,843
| – | – | 0.39% | 47 |
|
|
2020
Q1 | $2.26M | Hold |
30,843
| – | – | 0.44% | 45 |
|
|
2019
Q4 | $2.68M | Hold |
30,843
| – | – | 0.41% | 45 |
|
|
2019
Q3 | $2.48M | Hold |
30,843
| – | – | 0.41% | 44 |
|
|
2019
Q2 | $2.47M | Hold |
30,843
| – | – | 0.42% | 41 |
|
|
2019
Q1 | $2.45M | Buy |
30,843
+185
| +0.6% | +$13.8K | 0.42% | 41 |
|
|
2018
Q4 | $2.23M | Hold |
30,658
| – | – | 0.43% | 41 |
|
|
2018
Q3 | $2.08M | Hold |
30,658
| – | – | 0.36% | 41 |
|
|
2018
Q2 | $1.78M | Hold |
30,658
| – | – | 0.33% | 48 |
|
|
2018
Q1 | $1.59M | Buy |
30,658
+222
| +0.7% | +$12K | 0.29% | 49 |
|
|
2017
Q4 | $1.63M | Hold |
30,436
| – | – | 0.3% | 50 |
|
|
2017
Q3 | $1.86M | Buy |
30,436
+660
| +2% | +$40K | 0.37% | 45 |
|
|
2017
Q2 | $1.82M | Hold |
29,776
| – | – | 0.37% | 44 |
|
|
2017
Q1 | $1.8M | Hold |
29,776
| – | – | 0.37% | 46 |
|
|
2016
Q4 | $1.67M | Hold |
29,776
| – | – | 0.35% | 46 |
|
|
2016
Q3 | $1.77M | Sell |
29,776
-524
| -2% | -$30.6K | 0.38% | 45 |
|
|
2016
Q2 | $1.67M | Hold |
30,300
| – | – | 0.36% | 48 |
|
|
2016
Q1 | $1.53M | Hold |
30,300
| – | – | 0.34% | 47 |
|
|
2015
Q4 | $1.53M | Hold |
30,300
| – | – | 0.35% | 47 |
|
|
2015
Q3 | $1.43M | Sell |
30,300
-54
| -0.2% | -$2.87K | 0.34% | 48 |
|
|
2015
Q2 | $1.65M | Hold |
30,354
| – | – | 0.38% | 48 |
|
|
2015
Q1 | $1.67M | Sell |
30,354
-1,560
| -5% | -$88.3K | 0.4% | 47 |
|
|
2014
Q4 | $1.73M | Hold |
31,914
| – | – | 0.4% | 46 |
|
|
2014
Q3 | $1.8M | Hold |
31,914
| – | – | 0.46% | 46 |
|
|
2014
Q2 | $1.76M | Buy |
31,914
+1,572
| +5% | +$85.8K | 0.44% | 46 |
|
|
2014
Q1 | $1.64M | Hold |
30,342
| – | – | 0.42% | 48 |
|
|
2013
Q4 | $1.45M | Hold |
30,342
| – | – | 0.38% | 49 |
|
|
2013
Q3 | $1.38M | Sell |
30,342
-1,142
| -4% | -$52.1K | 0.39% | 49 |
|
|
2013
Q2 | $1.4M | Buy |
+31,484
| New | +$1.41M | 0.42% | 47 |
|
Other funds holding MRK
ECSS
ATO
Harvey Investment Company's MRK Position: Q2 2026 in Review
Harvey Investment Company reduced its Merck (MRK) stake by 1.7% in Q2 2026, selling an estimated $58.5K and leaving 28,754 shares worth $3.69M. The position accounts for 0.4% of the portfolio, ranked #40.
Harvey Investment Company first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.87M in Q1 2024. 1,620 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Harvey Investment Company held 28,754 shares of Merck worth $3.69M as of Q2 2026.
- Harvey Investment Company sold 500 Merck shares in Q2 2026, an estimated $58.5K.
- Merck made up 0.4% of Harvey Investment Company's portfolio in Q2 2026, its #40 holding.
- Harvey Investment Company first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
- Harvey Investment Company's Merck position peaked at $3.87M in Q1 2024.
- 1,620 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Harvey Investment Company's 13F filing for Q2 2026, filed 22 Jul 2026.